Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral application.
about
Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysisC5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge.Simultaneous measurement of etravirine, maraviroc and raltegravir in pigtail macaque plasma, vaginal secretions and vaginal tissue using a LC-MS/MS assay.Pharmacokinetics of the protein microbicide 5P12-RANTES in sheep following single dose vaginal gel administration.On-demand microbicide products: design matters.Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.
P2860
Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral application.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics of a CCR5 inh ...... , rectal and oral application.
@en
Pharmacokinetics of a CCR5 inh ...... , rectal and oral application.
@nl
type
label
Pharmacokinetics of a CCR5 inh ...... , rectal and oral application.
@en
Pharmacokinetics of a CCR5 inh ...... , rectal and oral application.
@nl
prefLabel
Pharmacokinetics of a CCR5 inh ...... , rectal and oral application.
@en
Pharmacokinetics of a CCR5 inh ...... , rectal and oral application.
@nl
P2093
P2860
P356
P1476
Pharmacokinetics of a CCR5 inh ...... , rectal and oral application.
@en
P2093
Deborah Lowry
John P Moore
Laurie Goldman
Leslie Geer
P J Klasse
Peter Boyd
R Karl Malcolm
Ronald S Veazey
P2860
P304
P356
10.1093/JAC/DKT506
P407
P577
2013-12-30T00:00:00Z